These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9245203)

  • 21. [Comparison of PSAD and PSAD-TZ value in prostatic hyperplasia and prostatic cancer].
    Fu Q; Yao DH; Jiang YQ
    Zhonghua Nan Ke Xue; 2002 Dec; 8(6):411-3. PubMed ID: 12593013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
    Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
    Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of prostate specific antigen (PSA) adjusted to transition zone in prostatic cancer detection].
    Jara Rascón J; Subirá Rios D; Lledó Garcia E; Martínez Salamanca JI; Moncada Iribarren I; Hernández Fernández C
    Actas Urol Esp; 2005 May; 29(5):485-92. PubMed ID: 16013794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.
    Taneja SS; Tran K; Lepor H
    Urology; 2001 Aug; 58(2):222-7. PubMed ID: 11489705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
    Ohori M; Dunn JK; Scardino PT
    Urology; 1995 Nov; 46(5):666-71. PubMed ID: 7495118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen.
    Aus G; Bergdahl S; Hugosson J; Lodding P; Norlén L
    Scand J Urol Nephrol; 1994 Dec; 28(4):379-84. PubMed ID: 7533925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An artificial neural network to predict the outcome of repeat prostate biopsies.
    Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
    Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer.
    Ferreira MD; Koff WJ
    Int Braz J Urol; 2005; 31(2):137-45; discussion 146. PubMed ID: 15877833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer.
    Mochtar CA; Rahardjo D; Umbas R
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():514-22. PubMed ID: 10895203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
    Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Likelihood of prostate cancer based on prostate-specific antigen density by MRI: retrospective analysis.
    Mueller-Lisse UG; Mueller-Lisse UL; Haller S; Schneede P; Scheidler JE; Schmeller N; Hofstetter AG; Reiser MF
    J Comput Assist Tomogr; 2002; 26(3):432-7. PubMed ID: 12016375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity and accuracy of TRUS-measured PSA-density and transition zone-PSA in the diagnosis of prostate cancer.
    Michielsen DP; De Boe VR; Braeckman JG; Keuppens FI
    Eur J Ultrasound; 1998 Nov; 8(2):125-8. PubMed ID: 9845794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].
    Kihara T; Ito F; Kobayashi C; Ryoji O; Tokumoto T; Iguchi Y; Maeda Y; Onizuka S; Goya N; Nakazawa H; Toma H
    Hinyokika Kiyo; 1997 Jan; 43(1):13-8. PubMed ID: 9046415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does PSA density of the transition zone represent a useful parameter in the diagnosis of prostate carcinoma?].
    Monesi G; Sala M; Baietto S; Minocci D; Kocjancic E; Marchioro G; Frea B
    Arch Ital Urol Androl; 2000 Dec; 72(4):182-9. PubMed ID: 11221033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of prostate specific antigen density as a screening method for prostatic carcinoma.
    Chakrabarti S; Raha K; Bhunia CL; Bhattachary DK
    J Indian Med Assoc; 2001 Nov; 99(11):627-8, 630. PubMed ID: 12022203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
    Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
    Hinyokika Kiyo; 1998 Sep; 44(9):639-43. PubMed ID: 9805668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.